{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for azelaic root_modifications_structuralModifications_molecularFragment_refPname in root_modifications_structuralModifications_molecularFragment_refPname (approximate match)
Status:
Investigational
Source:
INN:atisnolerbart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:cantuzumab ravtansine [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04723394: Phase 3 Interventional Completed COVID-19
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02573324: Phase 3 Interventional Completed Glioblastoma
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:tulisokibart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02038764: Phase 1 Interventional Completed Diabetes Mellitus, Type 1
(2014)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:divozilimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04602000: Phase 2/Phase 3 Interventional Completed SARS-CoV-2 Infection
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04619420: Phase 2 Interventional Active, not recruiting Alzheimer Disease
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04448379: Phase 1 Interventional Unknown status Locally Advanced or Metastatic Non-Small Cell Lung Cancer
(2020)
Source URL:
Class:
PROTEIN
